Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Fennec Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Fennec Pharmaceuticals Inc. June 10, 202698.8%
-
Fennec Pharmaceuticals Inc. June 3, 202597.5%
-
Fennec Pharmaceuticals Inc. June 25, 202492.5%
-
Fennec Pharmaceuticals Inc. June 12, 202399.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 11, 2026 | Fennec Pharmaceuticals Inc. | Option exercise | +14,344 | $2.44 | $34,999 |
| May 11, 2026 | Fennec Pharmaceuticals Inc. | Open-market sale | −8,346 | $7.04 | $58,756 |
| Oct 10, 2025 | Fennec Pharmaceuticals Inc. | Option exercise | +4,062 | $1.23 | $4,996 |
| Oct 10, 2025 | Fennec Pharmaceuticals Inc. | Open-market sale | −1,775 | $9.24 | $16,401 |
| Jul 7, 2025 | Fennec Pharmaceuticals Inc. | Option exercise | +2,127 | $2.35 | $4,998 |
| Jul 7, 2025 | Fennec Pharmaceuticals Inc. | Open-market sale | −1,119 | $8.71 | $9,746 |
| Apr 11, 2025 | Fennec Pharmaceuticals Inc. | Option exercise | +2,173 | $2.30 | $4,998 |
| Apr 11, 2025 | Fennec Pharmaceuticals Inc. | Open-market sale | −1,409 | $4.95 | $6,975 |
| Feb 14, 2025 | Fennec Pharmaceuticals Inc. | Option exercise | +1,992 | $2.51 | $5,000 |
| Feb 14, 2025 | Fennec Pharmaceuticals Inc. | Open-market sale | −1,186 | $6.82 | $8,089 |
| Dec 2, 2024 | Fennec Pharmaceuticals Inc. | Option exercise | +10,000 | $2.69 | $26,900 |
| Dec 2, 2024 | Fennec Pharmaceuticals Inc. | Open-market sale | −6,409 | $6.14 | $39,351 |
| Oct 8, 2024 | Fennec Pharmaceuticals Inc. | Option exercise | +1,960 | $2.55 | $4,998 |
| Oct 8, 2024 | Fennec Pharmaceuticals Inc. | Open-market sale | −1,406 | $4.53 | $6,369 |
| Jul 5, 2024 | Fennec Pharmaceuticals Inc. | Option exercise | +1,792 | $2.79 | $5,000 |
Questions about Chris A. Rallis
What boards is Chris A. Rallis on?
Chris A. Rallis sits on the board of Fennec Pharmaceuticals Inc.
How long has Chris A. Rallis served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.